welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Quest Diagnostics Launches Three Genetic Test Panels for Predicting Hereditary Cancer Risk
Quest Diagnostics launches three new test panels under its Quest Vantage brand. The lab-developed panels employ next-generation sequencing and a proprietary bioinformatics platform to identify genetic mutations associated with inherited risk of 15 cancers. According to the company, ~170K diagnoses are made in the U.S. each year of cancers that result from inherited genetic mutations. The tests only include genes that meet certain criteria such as a 2x increase in cancer risk, an association with a disease syndrome where cancer may occur and guideline support for genetic counseling. Quest will showcase the new panels at ASCO in Chicago.
expertly curated content related to this topic
- Familial Adenomatous Polyposis: Johns Hopkins Guide to the Diagnosis, Treatment and Prevention of ConditionMany patients with colorectal cancer exp...
- Attitudes Toward Genetic Testing in Childhood and Reproductive Decision-Making for Familial Adenomatous PolyposisChildhood DNA testing, prenatal diagnosi...
- Myh-Associated Polyposis (Approved by the Cancer.Net Editorial Board)MYH-associated polyposis (MAP) is a here...
- The Natural History of Familial Adenomatous Polyposis Syndrome: A 24 Year Review of a Single Center Experience in Sc...PURPOSE : Understanding the natural hist...
- ACMG Technical Standards and Guidelines for Genetic testing for Inherited Colorectal Cancer (Lynch Syndrome, Familia...Lynch syndrome, familial adenomatous pol...
- Lynch Syndrome and MYH-Associated Polyposis: Review and Testing StrategyIndividuals with Lynch syndrome have an ...
- FAP-AFAP-MAP: Indications for Testinghttps://media.springernature.com/full/sp...
English
Portuguese
Spanish